Log in to save to my catalogue

Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for...

Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5bf1810ca514d98bba32bc385eccbf7

Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment

About this item

Full title

Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-12, Vol.15 (1), p.10766-10, Article 10766

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Best1 and Best2 are two members of the bestrophin family of anion channels critically involved in the prevention of retinal degeneration and maintenance of intraocular pressure, respectively. Here, we solved glutamate- and γ-aminobutyric acid (GABA)-bound Best2 structures, which delineate an intracellular glutamate binding site and an extracellular...

Alternative Titles

Full title

Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b5bf1810ca514d98bba32bc385eccbf7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5bf1810ca514d98bba32bc385eccbf7

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-54938-z

How to access this item